Tyvaso DPI

Product NDC: 66302-600
Requested package NDC: 66302-600-02
11-digit product format: 663020600
Labeler code: 66302
Product ID: 66302-600_46c30322-3a4d-41f0-b7c1-1e4aba4831be
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: treprostinil
Dosage form: KIT
Labeler: United Therapeutics Corporation
Application: NDA214324
Marketing category: NDA
Marketing start: 2022-05-23
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	66302-600	66302-600-02	D	Discontinued by firm		2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N214324-001	TYVASO DPI	TREPROSTINIL	0.016MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23
N214324-002	TYVASO DPI	TREPROSTINIL	0.032MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23
N214324-003	TYVASO DPI	TREPROSTINIL	0.048MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23
N214324-004	TYVASO DPI	TREPROSTINIL	0.064MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23
N214324-005	TYVASO DPI	TREPROSTINIL	0.08MG/INH	POWDER / INHALATION	RLD, RS	2024-10-24

Orange Book patents#

Current patent rows page 1 of 1 · 30 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N214324-001	11357782	2027-05-14	U-1849		2025-04-24
N214324-001	11723887	2028-12-15		Drug substance	2023-08-15
N214324-001	9593066	2028-12-15		Drug substance	2022-06-17
N214324-001	10772883	2030-06-11		Drug product	2022-06-17
N214324-001	10421729	2035-04-01		Drug product	2022-06-17
N214324-001	11826327	2042-02-03	U-3749		2023-11-28
N214324-002	11357782	2027-05-14	U-1849		2025-04-24
N214324-002	11723887	2028-12-15		Drug substance	2023-08-15
N214324-002	9593066	2028-12-15		Drug substance	2022-06-17
N214324-002	10772883	2030-06-11		Drug product	2022-06-17
N214324-002	10421729	2035-04-01		Drug product	2022-06-17
N214324-002	11826327	2042-02-03	U-3749		2023-11-28
N214324-003	11357782	2027-05-14	U-1849		2025-04-24
N214324-003	11723887	2028-12-15		Drug substance	2023-08-15
N214324-003	9593066	2028-12-15		Drug substance	2022-06-17
N214324-003	10772883	2030-06-11		Drug product	2022-06-17
N214324-003	10421729	2035-04-01		Drug product	2022-06-17
N214324-003	11826327	2042-02-03	U-3749		2023-11-28
N214324-004	11357782	2027-05-14	U-1849		2025-04-24
N214324-004	11723887	2028-12-15		Drug substance	2023-08-15
N214324-004	9593066	2028-12-15		Drug substance	2022-06-17
N214324-004	10772883	2030-06-11		Drug product	2022-06-17
N214324-004	10421729	2035-04-01		Drug product	2022-06-17
N214324-004	11826327	2042-02-03	U-3749		2023-11-28
N214324-005	11357782	2027-05-14	U-1849		2025-04-24
N214324-005	11723887	2028-12-15		Drug substance	2024-11-18
N214324-005	9593066	2028-12-15		Drug substance	2024-11-18
N214324-005	10772883	2030-06-11		Drug product	2024-11-18
N214324-005	10421729	2035-04-01		Drug product	2024-11-18
N214324-005	11826327	2042-02-03	U-3749		2024-11-18

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	N214324-001	TYVASO DPI	0.016MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	TYVASO DPI	0.032MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	TYVASO DPI	0.048MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	TYVASO DPI	0.064MG/INH	POWDER / INHALATION	RLD, RS	2022-05-23	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	TYVASO DPI	0.08MG/INH	POWDER / INHALATION	RLD, RS	2024-10-24	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-01 22:54:32	2026-06	N214324-001	11357782	2027-05-14	U-1849		2025-04-24	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-001	11723887	2028-12-15		Drug substance	2023-08-15	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-001	9593066	2028-12-15		Drug substance	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-001	10772883	2030-06-11		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-001	10421729	2035-04-01		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-001	11826327	2042-02-03	U-3749		2023-11-28	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	11357782	2027-05-14	U-1849		2025-04-24	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	11723887	2028-12-15		Drug substance	2023-08-15	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	9593066	2028-12-15		Drug substance	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	10772883	2030-06-11		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	10421729	2035-04-01		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-002	11826327	2042-02-03	U-3749		2023-11-28	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	11357782	2027-05-14	U-1849		2025-04-24	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	11723887	2028-12-15		Drug substance	2023-08-15	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	9593066	2028-12-15		Drug substance	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	10772883	2030-06-11		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	10421729	2035-04-01		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-003	11826327	2042-02-03	U-3749		2023-11-28	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	11357782	2027-05-14	U-1849		2025-04-24	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	11723887	2028-12-15		Drug substance	2023-08-15	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	9593066	2028-12-15		Drug substance	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	10772883	2030-06-11		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	10421729	2035-04-01		Drug product	2022-06-17	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-004	11826327	2042-02-03	U-3749		2023-11-28	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	11357782	2027-05-14	U-1849		2025-04-24	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	11723887	2028-12-15		Drug substance	2024-11-18	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	9593066	2028-12-15		Drug substance	2024-11-18	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	10772883	2030-06-11		Drug product	2024-11-18	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	10421729	2035-04-01		Drug product	2024-11-18	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N214324-005	11826327	2042-02-03	U-3749		2024-11-18	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tyvaso DPI	TREPROSTINIL	United Therapeutics Corporation	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	2025-11-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 214324 application number: NDA214324 ndc (package): 66302-600-02 ndc (product): 66302-600 ndc11 (package): 66302060002

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d31d7280-9cbd-4e8c-ad8c-a830d9d6c4bf	Product name	1	20260309
3a764347-294a-401b-979f-44c1c6bb101a	Product name	1	20230126
5e14eefc-ad08-9fbf-a28c-67c518b16369	Product name	5	20210727
799cd7a2-692a-4730-993b-8b702e954a56	Product name	1	20200407

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66302-600-02	Tyvaso DPI	1 in 1 PACKAGE	KIT	1		14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66302-600-02	EA - Each	66302-600	12be41cd-f06c-4a20-a0f3-104f7b31f67c	1	2022-07-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66302-600	TYVASO DPI (TREPROSTINIL) INHALANT TYVASO DPI (TREPROSTINIL) KIT [UNITED THERAPEUTICS CORPORATION]	11	Legacy NDC, 1 package rows	20241222_ddc3d400-bcb3-4b09-aae2-0768b10a5b0f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
RUM6K67ESG	TREPROSTINIL	81846-19-7	treprostinil

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2602770	{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 28 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32-48 MCG Titration Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641914	{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-48-64 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602768	{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602774	{112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-48 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641907	{112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-64 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641912	{112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-64 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727471	{112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-80 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727473	{112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 64-80 MCG Maintenance Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602772	{16 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 16 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-48 MCG Institutional Pack]	BPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602769	{112 (treprostinil 0.016 MG Inhalation Powder) / 112 (treprostinil 0.032 MG Inhalation Powder) / 28 (treprostinil 0.048 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641913	{112 (treprostinil 0.016 MG Inhalation Powder) / 112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602767	{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602773	{112 (treprostinil 0.032 MG Inhalation Powder) / 112 (treprostinil 0.048 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641906	{112 (treprostinil 0.032 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641911	{112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727470	{112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727472	{112 (treprostinil 0.064 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602771	{16 (treprostinil 0.032 MG Inhalation Powder) / 16 (treprostinil 0.048 MG Inhalation Powder) } Pack	GPCK	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602751	treprostinil 16 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602767	treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602769	treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641913	treprostinil 16-48-64 MCG Maintenance Pack, 112 (16 MCG), 112 (48 MCG), 112 (64 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602756	treprostinil 32 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602771	treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602773	treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641906	treprostinil 32-64 MCG Maintenance Pack, 112 (32 MCG), 112 (64 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602760	treprostinil 48 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641911	treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727470	treprostinil 48-80 MCG Titration Pack, 112 (48 MCG), 112 (80 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602764	treprostinil 64 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727472	treprostinil 64-80 MCG Titration Pack, 112 (64 MCG), 112 (80 MCG)	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697737	treprostinil 80 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602754	TYVASO DPI 16 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602768	Tyvaso DPI 16-32 MCG Titration Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602770	Tyvaso DPI 16-32-48 MCG Titration Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641914	Tyvaso DPI 16-48-64 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602758	TYVASO DPI 32 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602772	Tyvaso DPI 32-48 MCG Institutional Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602774	Tyvaso DPI 32-48 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641907	Tyvaso DPI 32-64 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602762	TYVASO DPI 48 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641912	Tyvaso DPI 48-64 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727471	Tyvaso DPI 48-80 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602766	TYVASO DPI 64 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727473	Tyvaso DPI 64-80 MCG Maintenance Pack	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697739	TYVASO DPI 80 MCG Inhalation Powder	PSN	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602754	treprostinil 0.016 MG Inhalation Powder [Tyvaso]	SBD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602758	treprostinil 0.032 MG Inhalation Powder [Tyvaso]	SBD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602762	treprostinil 0.048 MG Inhalation Powder [Tyvaso]	SBD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602766	treprostinil 0.064 MG Inhalation Powder [Tyvaso]	SBD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697739	treprostinil 0.08 MG Inhalation Powder [Tyvaso]	SBD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602751	treprostinil 0.016 MG Inhalation Powder	SCD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602756	treprostinil 0.032 MG Inhalation Powder	SCD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602760	treprostinil 0.048 MG Inhalation Powder	SCD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602764	treprostinil 0.064 MG Inhalation Powder	SCD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697737	treprostinil 0.08 MG Inhalation Powder	SCD	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602751	treprostinil 16 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602767	treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602769	treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641913	treprostinil 16-48-64 MCG Maintenance Pack, 112 (16 MCG), 112 (48 MCG), 112 (64 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602756	treprostinil 32 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602771	treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602773	treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641906	treprostinil 32-64 MCG Maintenance Pack, 112 (32 MCG), 112 (64 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602760	treprostinil 48 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2641911	treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727470	treprostinil 48-80 MCG Titration Pack, 112 (48 MCG), 112 (80 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602764	treprostinil 64 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2727472	treprostinil 64-80 MCG Titration Pack, 112 (64 MCG), 112 (80 MCG)	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697737	treprostinil 80 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602754	Tyvaso 0.016 MG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602758	Tyvaso 0.032 MG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602762	Tyvaso 0.048 MG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602766	Tyvaso 0.064 MG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697739	Tyvaso 0.08 MG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602754	Tyvaso 16 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602758	Tyvaso 32 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602762	Tyvaso 48 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2602766	Tyvaso 64 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14
2697739	Tyvaso 80 MCG Inhalation Powder	SY	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
66302-600-02	66302060002	1 KIT in 1 PACKAGE (66302-600-02) * 4 INHALANT in 1 BLISTER PACK * 4 INHALANT in 1 BLISTER PACK	1 kit	2022-05-23	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Tyvaso DPI - United Therapeutics Corporation	United Therapeutics Corporation	2025-11-20	HUMAN PRESCRIPTION DRUG LABEL	14